Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Pain|February 27, 2020
Distribution of functional opioid receptors in human dorsal root ganglion neuronsJamie K Moy, Jane E Hartung, Melissa G Duque, et al.
Molecular and Cellular Neurosciences|February 6, 2008
Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout miceThomas Christoph, Gregor Bahrenberg, Jean De Vry, et al.
Neurochemistry International|October 19, 2006
Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1Thomas Christoph, Clemens Gillen, Joanna Mika, et al.
Expert Opinion on Pharmacotherapy|June 16, 2012
Mechanistic and functional differentiation of tapentadol and tramadolRobert B Raffa, Helmut Buschmann, Thomas Christoph, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 28, 2007
(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic propertiesThomas M Tzschentke, Thomas Christoph, Babette Kögel, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2017
Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonistsSunho Lee, Changhoon Kim, Jihyae Ann, et al.
Drugs of Today (Barcelona, Spain : 1998)|October 17, 2009
Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single moleculeThomas M Tzschentke, Ulrich Jahnel, Babette Kogel, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2020
Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl)methyl) ureas as potent and thermoneutral TRPV1 antagonistsJin Mi Kang, Sun Ok Kwon, Jihyae Ann, et al.
Journal of Medicinal Chemistry|July 26, 2014
Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonistsChristian Bourgeois, Elena Werfel, Fabian Galla, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2014
First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG)Lars Arne Berger, Carsten Bokemeyer, Anja Lorch, et al.
Pageof 8